MX2021001030A - Micronized and activated zeolite, process for the preparation thereof, and the use thereof as oxidative stress modulator and detoxifier. - Google Patents
Micronized and activated zeolite, process for the preparation thereof, and the use thereof as oxidative stress modulator and detoxifier.Info
- Publication number
- MX2021001030A MX2021001030A MX2021001030A MX2021001030A MX2021001030A MX 2021001030 A MX2021001030 A MX 2021001030A MX 2021001030 A MX2021001030 A MX 2021001030A MX 2021001030 A MX2021001030 A MX 2021001030A MX 2021001030 A MX2021001030 A MX 2021001030A
- Authority
- MX
- Mexico
- Prior art keywords
- detoxifier
- micronized
- oxidative stress
- preparation
- stress modulator
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to a micronized and activated natural zeolite, a process for the preparation thereof, and the use thereof as systemic oxidative stress modulator and detoxifier in humans, by means of the increase in blood levels of antioxidant enzymes, the reduction in lipid peroxidation, and detoxification. In particular, this is a micronized and activated natural zeolite with a particle size of from 1 to 11 microns, a surface area of 20 to 40 m<sup>2</sup>/g, thermal activation at a temperature of between 200°C and 300°C for 2 to 4 hours, and tribochemical activation treated in the dry state in a high-intensity turbomixer, at a speed of between 850 and 7500 rpm, at a temperature of between 25°C and 100°C, for 10 to 30 minutes. The product of the present invention may be used as systemic oxidative stress modulator and detoxifier in a number of pathological conditions, such as cardiovascular diseases, endothelial dysfunction, diabetes mellitus, cancer or metabolic syndrome by means of the production of pharmaceutical preparations and food supplements in the form of powder, tablets, hard capsules, soft capsules, suspensions, etc.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2021001030A MX2021001030A (en) | 2015-09-30 | 2015-09-30 | Micronized and activated zeolite, process for the preparation thereof, and the use thereof as oxidative stress modulator and detoxifier. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2021001030A MX2021001030A (en) | 2015-09-30 | 2015-09-30 | Micronized and activated zeolite, process for the preparation thereof, and the use thereof as oxidative stress modulator and detoxifier. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021001030A true MX2021001030A (en) | 2021-04-19 |
Family
ID=85476754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021001030A MX2021001030A (en) | 2015-09-30 | 2015-09-30 | Micronized and activated zeolite, process for the preparation thereof, and the use thereof as oxidative stress modulator and detoxifier. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX2021001030A (en) |
-
2015
- 2015-09-30 MX MX2021001030A patent/MX2021001030A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Minzanova et al. | Biological activity and pharmacological application of pectic polysaccharides: A review | |
| JP6009467B2 (en) | Spray dried myrosinase and use for producing isothiocyanate | |
| Zhang et al. | The modulatory effect of anthocyanins from purple sweet potato on human intestinal microbiota in vitro | |
| Deniz et al. | Supercritical fluid extraction of phycocyanin and investigation of cytotoxicity on human lung cancer cells | |
| Liao et al. | Intracellular antioxidant detoxifying effects of diosmetin on 2, 2-azobis (2-amidinopropane) dihydrochloride (AAPH)-induced oxidative stress through inhibition of reactive oxygen species generation | |
| JP2007535575A (en) | Biologically active compounds and methods of use thereof | |
| NZ602557A (en) | Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | |
| JP2014508156A5 (en) | ||
| JP2010209051A (en) | Fat absorption inhibitor | |
| MX2012014062A (en) | Solid core coacervated capsules. | |
| Zhang et al. | A multifaceted review on dihydromyricetin resources, extraction, bioavailability, biotransformation, bioactivities, and food applications with future perspectives to maximize its value | |
| PE20140803A1 (en) | NUTRITIONAL COMPOSITIONS THAT HAVE SOLID PARTICLES AND METHODS TO MAKE AND USE THEM | |
| EA201690196A1 (en) | PROBIOTICS FOR EXCESSLY FLOWERS | |
| JP2011137150A5 (en) | ||
| WO2018230960A3 (en) | Novel bifidobacterium bifidum strain and strain-derived polysaccharide | |
| MX2018016032A (en) | Novel silybum marianum achene extract and uses thereof in dermatology and dermo-cosmetics. | |
| CN106562422A (en) | Preparation technology of ganoderma lucidum spore oil and lycopene soft capsules | |
| Blazheva et al. | Antioxidant potential of probiotics and postbiotics: a biotechnological approach to improving their stability | |
| MX2015013897A (en) | Micronized and activated zeolite, process for the preparation thereof, and the use thereof as oxidative stress modulator and detoxifier. | |
| MX351668B (en) | Activated, micronized zeolite, method for activating and micronizing same and use thereof as a carrier in pharmaceutical preparations and dietary supplements. | |
| MX2021001030A (en) | Micronized and activated zeolite, process for the preparation thereof, and the use thereof as oxidative stress modulator and detoxifier. | |
| Pattiram et al. | Edible oils as a co-extractant for the supercritical carbon dioxide extraction of flavonoids from propolis | |
| JP2015120759A5 (en) | Composition for reducing blood neutral fat, method for producing the same, and functional food for reducing blood neutral fat | |
| WO2017220051A3 (en) | Benserazide hydrochloride pharmaceutical composition and medical use thereof for lowering blood sugar | |
| JP6695535B1 (en) | Blood pressure elevation inhibitor, food additive and food and drink |